Financial Ratios

KDL BIOTECH LTD.

NSE : NABSE : 532291ISIN CODE : INE746A01010Industry : Pharmaceuticals & DrugsHouse : Parijat
BSE2.140 (0 %)
PREV CLOSE ( ) 2.14
OPEN PRICE ( ) 2.14
BID PRICE (QTY) 2.14 (584)
OFFER PRICE (QTY) 2.36 (1)
VOLUME 4811
TODAY'S LOW / HIGH ( )2.14 2.14
52 WK LOW / HIGH ( ) 2.142.14
NSE
This Company is not listed in NSE
Select year
ParticularsMar2012Mar2011Mar2010Sep2008Sep2007
Operational & Financial Ratios
   Earnings Per Share (Rs)-7.16-26.76-7.08-8.79-8.08
   CEPS(Rs)-3.36-17.46-1.92-5.92-2.00
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-24.62-17.469.3016.38-0.16
   Tax Rate(%)0.00-13.59-0.13-0.20-0.48
Margin Ratios
   Core EBITDA Margin(%)-7.58-56.34-25.53-15.74-6.01
   EBIT Margin(%)-38.31-171.82-35.33-17.85-0.30
   Pre Tax Margin(%)-63.15-195.04-42.86-35.04-7.51
   PAT Margin (%)-63.15-221.53-42.92-35.11-7.54
   Cash Profit Margin (%)-29.64-144.55-11.63-23.65-1.87
Performance Ratios
   ROA(%)-28.21-78.59-16.21-16.41-9.49
   ROE(%)0.000.00-55.12-108.110.00
   ROCE(%)-108.39-101.90-15.27-11.54-0.57
   Asset Turnover(x)0.450.350.380.471.26
   Sales/Fixed Asset(x)0.180.190.260.421.29
   Working Capital/Sales(x)-0.26-0.30-5.554.6022.49
Efficiency Ratios
   Fixed Capital/Sales(x)5.695.333.782.370.78
   Receivable days2.082.295.1171.6255.32
   Inventory Days34.9238.8039.94105.7344.67
   Payable days425.93647.98354.16343.2098.86
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-1.09-0.31-6.47-1.97-7.18
   Price/Book(x)-0.15-0.311.330.71-89.64
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)2.592.562.251.600.63
   EV/Core EBITDA(x)-52.39-4.53-10.46-23.6411.04
   EV/EBIT(x)-6.56-1.46-6.18-8.46-197.33
   EV/CE(x)1.211.110.880.810.73
   M Cap / Sales0.330.460.780.490.14
Growth Ratio
   Net Sales Growth(%)-6.83-25.98-32.49-66.47206.93
   Core EBITDA Growth(%)91.84-94.07-114.84-139.82489.76
   EBIT Growth(%)79.07-256.29-30.34-1888.0491.15
   PAT Growth(%)73.24-278.1319.51-55.97-20.11
   EPS Growth(%)73.24-278.1319.51-8.78-20.11
Financial Stability Ratios
   Total Debt/Equity(x)-1.02-1.432.571.63-308.82
   Current Ratio(x)0.060.060.731.841.13
   Quick Ratio(x)0.040.040.601.500.66
   Interest Cover(x)-1.54-7.40-4.69-1.04-0.04
   Total Debt/Mcap(x)6.854.641.922.293.44

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.